Dr. Byeong-Keuk Kim and Dr. C Michael Gibson Discuss: OCCUPI – Optical coherence tomography-guided coronary intervention in patients with complex lesions September 2, 2024
Dr. C Michael Gibson and Serge Korijan Discuss: Apolipoprotein A-I infusions and cardiovascular outcomes in patients with acute myocardial infarction and hyperlipidemia, ApoA-I Infusions and Burden of Ischemic Events after Acute Myocardial Infarction September 2, 2024 Disclosures: TBD
Dr. Holger Thiele and Dr. C Michael Gibson Discuss: Temporary mechanical circulatory support in infarct-related cardiogenic shock – An individual patient data meta-analysis of all randomized trials with 6-month follow-up September 2, 2024 Disclosures: TBD
Dr. Holger Thiele and Dr. C Michael Gibson Discuss: Extracorporeal life support for acute myocardial infarction complicated by cardiogenic shock – 12 months results of the ECLS-SHOCK trial September 2, 2024 Disclosures: TBD
Dr. Renato Lopes and Dr. C Michael Gibson Discuss: GUARD-AF – ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals September 1, 2024 Disclosures: TBD
Dr. Laust Dupont Rasmussen and Dr. C Michael Gibson Discuss: Assessment of the microvascular resistance reserve for predicting the effect of revascularization in patients with moderate coronary stenoses. September 1, 2024 Disclosures: TBD
Dr. David Ferreira and Dr. C Michael Gibson Discuss: SCOFF – Fasting or no fasting before cardiac cauterization procedures September 1, 2024 Disclosures: TBD
Dr. Gianluca Campo and Dr. C Michael Gibson Discuss: EARTH-STEMI – Complete vs. culprit-only revascularization in older STEMI patients September 1, 2024 Disclosures: TBD
Dr. Vijay Kunadian and Dr. C Michael Gibson Discuss: SENIOR RITA – Older patients with non-ST segment elevation myocardial infarction randomized interventional treatment trial September 1, 2024 Disclosures: TBD
Dr. Frans Berend Mensink, Dr. Dirk-Jan van Genus and Dr. C Michael Gibson Discuss: Functional Improvement of non-infarcT relaTed coronary artery stenosis by Extensive LDL-C Reduction with a PCSK9 Antibody September 1, 2024 Disclosures: TBD
